An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis - ScienceDirect
![PDF] Excellent response to tofacitinib treatment in a patient with alopecia universalis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/56d4fd1916703570c35a05eace9cb8fbeacba536/2-Figure2-1.png "PDF] Excellent response to tofacitinib treatment in a patient with alopecia universalis. | Semantic Scholar")
PDF] Excellent response to tofacitinib treatment in a patient with alopecia universalis. | Semantic Scholar
How JAK Inhibitor Hair Loss Treatments Were Discovered
Clinical response to baricitinib in CANDLE patient with AA. Scalp... | Download Scientific Diagram
Xconomy: With FDA's Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss
Frontiers | Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib | Immunology
Aclaris Announces Positive 6-Month Results for Androgenetic Alopecia | Hair Loss Cure 2020
Alopecia Treatment Phase II Trial Studies JAK Inhibitor CTP-543
References in Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata - Journal of the American Academy of Dermatology
Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib | HTML | Acta Dermato-Venereologica
New drug said to stimulate regrowth of a FULL head of hair in just four months
Topical Tofacitinib Trialled As Children's Alopecia Areata Treatment
Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment | SMJ
Drug reverses one baldness type; is male pattern next? | CNN
JAK inhibitors, A Promising Cure for Treating Skin and Hair Conditions - Trichology
Aclaris Updates Plans For Alopecia – Follicle Thought
JAK Inhibitors Show Great Potential as a Hair Loss Treatment – Follicle Thought
Dr. Sergio Vañó on Twitter: "Preparing a lecture about the promising new therapies for #AlopeciaAreata: the JAK inhibitors (@PierreFabre meeting at Barcelona, June 2018). #tricoHRC #tricologiaGPJ #tofacitinib #ruxolitinib #baricitinib #jakavi #xeljanz ...
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine
Strong Commitment' Made to JAK Inhibitor Hair Loss Treatment Development
At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors - JAAD Case Reports
Janus kinase inhibitors: An innovative treatment for alopecia areata - Park - 2019 - The Journal of Dermatology - Wiley Online Library
Is Inflammation to Blame for Hair Loss? Research Shows JAK Inhibitor Promotes Hair Growth - Dr. Movassaghi
